Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

BioChem Pharma reveals novel compounds for hepatitis C virus

Oct. 6, 2000

Final analysis of ISIS-2302 sparks reinitiation of development

Oct. 5, 2000

Ribozyme presents HBV data, announces formal HBV development program

Oct. 4, 2000

Anti-H. pylori agents prepared and tested at Welfide

Oct. 3, 2000

Efficacy in experimental IBD demonstrated for immunosteroid recently acquired by Hollis-Eden

Oct. 2, 2000

FDA approves Visicol

Sep. 29, 2000

Novel drug target identified for hepatitis B

Sep. 27, 2000

Zefix approved in Japan for chronic HBV infection

Sep. 26, 2000

Valentis and Viragen combine PEGylation technology and Omniferon for HCV therapy

Sep. 25, 2000

Therapeutically useful M3/5-HT4 antagonists patented by major French lab

Sep. 19, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...